Protecting Liver Health with Innovation | National Hepatitis Day

Hepatitis diagnostics

Protecting Liver Health with Innovation | National Hepatitis Day

As China’s first listed IVD company, KHB has been a pioneer in liver disease diagnostics since the 1990s. We developed China’s first ELISA reagent for Hepatitis B and C, playing a key role in advancing liver disease prevention and control.

Early Detection is Key to Preventing Liver Damage Hepatitis, a viral infection affecting millions globally, can lead to severe liver damage, including cirrhosis, liver failure, and even liver cancer if left untreated. Chronic hepatitis B and C infections are particularly dangerous, as they can often be asymptomatic in the early stages, making timely detection critical. With proper diagnosis and intervention, however, liver damage can be prevented or minimized, helping individuals lead healthier lives and reducing the global burden of liver disease.

With continuous innovation, we offer a comprehensive range of liver disease diagnostic solutions across biochemical, immunological, and molecular diagnostics. Our solutions are designed for high precision, featuring:

 Ultra-low detection limits for early and accurate diagnosis

 Wide quantification range to cover diverse clinical needs

 Strong anti-interference capability for reliable results

KHB dedicated to advancing hepatitis diagnostics and protecting liver health worldwide.On this National Liver Day, we reaffirm our commitment to improving liver disease detection through continuous innovation. Learn more:

https://www.skhb.com/en/product/newdetail_3698.html

https://www.skhb.com/en/product/newdetail_2568.html

https://www.skhb.com/en/product/newdetail_3859.html

https://www.skhb.com/en/product/newdetail_3857.html

#NationalHepatitisDay #LiverHealth #KHB #HBV #HCV